PMID- 34215792 OWN - NLM STAT- MEDLINE DCOM- 20211102 LR - 20240402 IS - 2045-2322 (Electronic) IS - 2045-2322 (Linking) VI - 11 IP - 1 DP - 2021 Jul 2 TI - A pseudohomogeneous nanocarrier based on carbon quantum dots decorated with arginine as an efficient gene delivery vehicle. PG - 13790 LID - 10.1038/s41598-021-93153-4 [doi] LID - 13790 AB - A pseudohomogeneous carrier as an emerging term refers to subnanometric carbon-based vehicle with a high ability to interact with genetic materials to form stable carboplex and successfully transfer them into the cell which will result in inhibiting or expressing of therapeutic genes. Chitosan is a non-toxic polyaminosaccharide used as a precursor in the presence of citric acid to produce carbon quantum dots (CQDs), which decorated with arginine as a surface passivation agent with high amine density in hydrothermal methodology. The Arginine-CQDs are comprehensively characterized by Fourier-transform infrared spectroscopy (FT-IR), Ultraviolet-visible spectroscopy (UV-vis), Atomic force microscopy (AFM), field emission scanning electron microscope (FE-SEM), Energy-dispersive X-ray (EDX) mapping, fluorescence, High-resolution transmission electron microscopy (HR-TEM), zeta potential and X-ray powder diffraction (XRD). In this regard, for the first time, carboplex are formed by electrostatic conjugating of Arginine-CQDs with DNA to protect it from enzymatic degradation. Moreover, the carboplex, like the chitosan precursor, has not shown toxicity against AGS cell line. Interestingly, the Arginine-CQDs have exhibited an excellent ability to overcome cell barriers to deliver into cells compared to chitosan at the same weight ratio. The Arginine-CQDs/pEGFP (W/W) nanocomplex, not only lead to transfection with a relatively higher efficiency than PEI polymer, which is the "golden standard", but carboplex also demonstrates no significant toxicity. Indeed, the EGFP expression level has reached to 2.4 +/- 0.2 via Arginine-CQDs carboplex at W/W 50 weight ratio. To the best of our knowledge, this is the first report includes chitosan-based CQDs functionalized by arginine which is applied to serve as a pseudohomogeneous vehicle for gene transfection. FAU - Rezaei, Aram AU - Rezaei A AD - Nano Drug Delivery Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran. aram.rezaei@gmail.com. FAU - Hashemi, Ehsan AU - Hashemi E AD - Department of Animal Biotechnology, National Institute of Genetic Engineering and Biotechnology, P.O. Box: 14965-16, Tehran, Iran. AD - Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20210702 PL - England TA - Sci Rep JT - Scientific reports JID - 101563288 RN - 0 (enhanced green fluorescent protein) RN - 147336-22-9 (Green Fluorescent Proteins) RN - 7440-44-0 (Carbon) RN - 9012-76-4 (Chitosan) RN - 94ZLA3W45F (Arginine) SB - IM MH - Arginine/chemistry/*genetics MH - Carbon/*chemistry MH - Chitosan/chemistry MH - Gene Expression Regulation/drug effects MH - Gene Transfer Techniques MH - Green Fluorescent Proteins/*genetics MH - Humans MH - Microscopy, Atomic Force MH - Nanoparticles/*chemistry MH - Quantum Dots/chemistry MH - Spectroscopy, Fourier Transform Infrared MH - Transfection/methods PMC - PMC8253742 COIS- The authors declare no competing interests. EDAT- 2021/07/04 06:00 MHDA- 2021/11/03 06:00 PMCR- 2021/07/02 CRDT- 2021/07/03 05:56 PHST- 2021/04/06 00:00 [received] PHST- 2021/06/22 00:00 [accepted] PHST- 2021/07/03 05:56 [entrez] PHST- 2021/07/04 06:00 [pubmed] PHST- 2021/11/03 06:00 [medline] PHST- 2021/07/02 00:00 [pmc-release] AID - 10.1038/s41598-021-93153-4 [pii] AID - 93153 [pii] AID - 10.1038/s41598-021-93153-4 [doi] PST - epublish SO - Sci Rep. 2021 Jul 2;11(1):13790. doi: 10.1038/s41598-021-93153-4.